SCHEMBL16147657

SCHEMBL16147657

CCCCc1cccc(C(=O)Nc2ccc(C#N)cc2Cl)c1O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK1 Q15118 1/20 0.44
PDK2 Q15119 1/20 0.44
PDK3 Q15120 1/20 0.44
PDK4 Q16654 1/20 0.44
ALOX15 P16050 1/20 0.43
KMT2A Q03164 2/20 0.41
RAB9A P51151 2/20 0.41
RXFP1 Q9HBX9 1/20 0.41
ACLY P53396 1/20 0.41
MAPK14 Q16539 1/20 0.39
SLC16A3 O15427 2/20 0.39
P2RX1 P51575 1/20 0.39
CYP1A2 P05177 2/20 0.39
CYP3A4 P08684 2/20 0.39
CYP2D6 P10635 2/20 0.39
CYP2C19 P33261 2/20 0.39
MEN1 O00255 1/20 0.39
CYP2C9 P11712 1/20 0.39
ALDH1A1 P00352 2/20 0.39
POLB P06746 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27667657 0.80 RORC (0.56) KMT2ARAB9ACYP1A2CYP3A4CYP2D6
SCHEMBL27701570 0.79 SLC16A3 (0.43) ALOX15RAB9ARXFP1SLC16A3CYP1A2
SCHEMBL24460157 0.73 MEN1 (0.55) PDK1PDK2PDK3PDK4ALOX15
SCHEMBL30742579 0.71 TRPV1 (0.56) KMT2ARAB9ACYP1A2CYP3A4CYP2C19
SCHEMBL14885885 0.71 TMPRSS4 (0.70) PDK1PDK2PDK3PDK4KMT2A
SCHEMBL30771735 0.71 TMPRSS4 (0.70) PDK1PDK2PDK3PDK4KMT2A
SCHEMBL678335 0.70 MAPT (0.46)
SCHEMBL29617490 0.70 GRM5 (0.56) PDK1PDK2PDK3PDK4KMT2A
SCHEMBL24460229 0.70 GRM5 (0.56) PDK1PDK2PDK3PDK4KMT2A
SCHEMBL7686835 0.70 EGLN1 (0.69) KMT2AMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014165816-A1 COMPOUNDS USEFUL FOR THE TREATMENT OF METABOLIC DISORDERS AND SYNTHESIS OF THE SAME NORTH CAROLINA CENTRAL UNIVERSITY (US) 2014-10-09 WO disclosed